Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: A possible mode of action in Parkinson's disease
- 30 September 1971
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 16 (1), 27-38
- https://doi.org/10.1016/0014-2999(71)90053-7
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Effects of desipramine, phentolamine and phenoxybenzamine on the release of noradrenaline from isolated tissuesJournal of Pharmacy and Pharmacology, 1970
- Antagonism by amantadine of prochlorpemazine-induced catalepsyJournal of Pharmacy and Pharmacology, 1970
- AMANTADINE IN PARKINSON'S DISEASEThe Lancet, 1970
- MICROFLUORIMETRIC STUDIES ON THE FORMALDEHYDE-INDUCED FLUORESCENCE OF NORADRENALINE IN ADRENERGIC NERVES OF RAT IRISJournal of Histochemistry & Cytochemistry, 1969
- Histochemical Studies on the Effect of Nerve Impulses on Exogenous Catecholamines Taken Up into the Adrenergic Nerves of Reserpine-pretreated AnimalsPharmacology, 1969
- Functional Role of the Nigro‐Neostriatal Dopamine Neurons*)Acta Pharmacologica et Toxicologica, 1966
- The Effect of DOPA on the Spinal Cord. 2. A Pharmacological AnalysisActa Physiologica Scandinavica, 1966
- Biochemical and Histochemical Studies on the Effects of Imipramine‐like Drugs and (+)‐Amphetamine on Central and Peripheral Catecholamine NeuronsActa Physiologica Scandinavica, 1966
- The influence of monoamine oxidase inhibition on catecholamine synthesisLife Sciences, 1966
- Cerebral metabolism of DOPA-C14 in ratsInternational Journal of Neuropharmacology, 1964